Email lpt.research@nhs.net to find out more about the studies below.
One in three people with a history of depression have not responded to treatment (NICE, 2018). RESTORE-LIFE aims to assess whether vagal nerve stimulation is effective as an adjunctive therapy in patients that have treatment resistant depression. This involves the surgical implantation of a pulse generator in the chest connected to the vagus nerve that stimulates the nerve for a set period of time.
PI: Dr Ganesh Kunjithapatham.
R&D Delivery Team: Jo Edgar and Jo McGarr
The Leicestershire Inpatient Rehabilitation Outcomes (LIRO) study aims to analyse inpatient rehabilitation service user data in LPT. This is to explore who the service users are, what outcomes they achieve and what their rehabilitation pathway looks like. This study is sponsored by LPT and is being run by Chief Investigator Dr Kelly Fenton alongside Dr Sandeep Singh and Dr Kat Kidd from the Enhanced Rehabilitation and Recovery Pathway.
The Genetic Links to Anxiety and Depression (GLAD) study aims to better understand depression and anxiety in order to find better treatments and improve the lives of people experiencing these
disorders. Participants in this study complete an online questionnaire and send a saliva DNA sample to the study team through the post. This study is open for people to participate, here is the link: https://gladstudy.org.uk/.R&D Delivery Team: Jo Edgar, Tom Pringle
The Genetic Links to Anxiety and Depression (GLAD) study aims to better understand depression and anxiety in order to find better treatments and improve the lives of people experiencing these
disorders. Participants in this study complete an online questionnaire and send a saliva DNA sample to the study team through the post. This study is open for people to participate, here is the link: https://gladstudy.org.uk/.Principal Investigator: Prof. Elizabeta Mukaetova Ladinska
Research Delivery Team: Dr Sarah Baillon, Tom Pringle, Victory Olutuase, Naomi Gurr
One in three people with psychosis have visions, also known as visual hallucinations, though only little is known about these experiences. VISION-QUEST aims to develop the understanding of visions in two ways. Firstly, by developing a new measure exploring peoples beliefs about visions and secondly, by exploring the relationships between visions and other issues. The study is open to people with psychosis aged between 16 – 65 who are currently experiencing visions.
Principal Investigator: Dr Kelly Fenton
Research Delivery Team: Jo McGarr, Tom Pringle
Co-PICS aims to improve the care of diverse people living with psychosis and multiple long-term conditions. This will be done by learning about their experiences followed by the co-design of resources. The resources developed will then be evaluated in their use and impact across England.
Principal Investigator: Dr Shiraz Ahmed
Research Delivery Team: Jo Brown, Naomi Gurr
DREAMS aims to understand how mental health practitioners identify and assist clients experiencing domestic abuse. The study uses surveys and interviews to focus on how mental health professionals identify and assist clients experiencing domestic abuse in intimate relationships, regardless of gender.
Principal Investigator: Dr Lois Dugmore
Research Delivery Team: Jo Brown
TRAUMA-AID is a randomised controlled trial to investigate Eye Movement Desensitisation and Reprocessing (EMDR) for symptoms of Post-Traumatic Stress Disorder (PTSD) in adults with intellectual disabilities. This study aims to evaluate whether EMDR provides value for money, improves the mental health and quality of life for people with intellectual difficulties who suffer PTSD when compared to standard available treatment.
Principal Investigator: Dr Peter Beardsworth
Research Delivery Team: Jo Brown
This study aims to investigate changes in the behaviour of people taking antipsychotic medication that leads to the development of metabolic side effects, including weight gain, high cholesterol and high blood sugars. People who get metabolic side effects are at high risk of getting type 2diabetes and heart disease. Individuals who have recently started taking,or are about to start taking, an antipsychotic medication and their family member, friend or carer will be invited to take part.
Principal Investigator: Dr Dolly Sud
Research Delivery Team: Joy Fellows, Victory Olutuase
The purpose of this project is to understand the most effective smoking cessation practices in supporting people with severe mental illness (SMI) to quit smoking. The research team aim to use this information to develop a gold standard for best practice of smoking cessation for people with SMI.
Principal Investigator: Dr Emily Lucocq
The Tracking Eye Movement and Pupil Light Response in dementia (TEMPLR) study aims to identify if the performance on eye movement and pupillometry tasks can be used as an early indicator of cognitive impairment in Alzheimer’s disease and mild cognitive impairment. If so, these tasks may be able to be used as a diagnostic tool.
Principal Investigator: Prof. Elizabeta Mukaetova-Ladinska
The data from NCISH has helped to inform patient safety in mental health settings, which in turn has helped to contribute to an overall reduction in suicide in the UK. This study is led by the Medical Director in LPT. More details about this enquiry can be found here: https://sites.manchester.ac.uk/ncish/
The information on this page is correct as of December 2024.